Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1Epstein-Barr Virus Infections 1

Interventions

pembrolizumab 1dehydroftorafur 1Watchful Waiting 1Taxes 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Platinum 1Paclitaxel 1Matrix-M 1Gemcitabine 1Fluorouracil 1Cisplatin 1Bevacizumab 1AP 1903 reagent 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Epstein-Barr Virus Infections × Matrix-M × Clear all
NCT04645147 2025-07-17

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
83 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡